Neothetics Initiates Study to Evaluate Safety of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Neothetics Initiates Study to Evaluate Safety of Retreatment With LIPO-202 for Body Contouring

SAN DIEGO, March 23, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq: NEOT ), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced it has initiated an open-label study to evaluate the safety of multiple courses of treatment of LIPO-202 (salmeterol xinafoate for injection) for the reduction of central abdominal bulging. This is a supplemental study that Neothetics expects to submit to the U.S. Food and Drug Administration (FDA) as part of the company's New Drug Application (NDA) package for LIPO-202.

The open-label, study – referred to as LIPO-202-CL-22 – will consist of three, eight-week courses of treatment with LIPO-202 with a three month period between treatments in non-obese adult subjects who have central abdominal bulging. Each course of treatment consists of 20 subcutaneous one m L injections of LIPO-202 (0.02 mcg salmeterol xinafoate/ m L; total dose of 0.40 mcg salmeterol xinafoate), administered once a week. The study utilizes the same dose of drug to be used in Neothetics' pivotal Phase 3 safety and efficacy trials. Neothetics expects to enroll 150 subjects at multiple centers in the U.S.

"LIPO-202 has demonstrated an extremely clean safety profile, equivalent to placebo in the six clinical trials conducted to date, and this study will give us insights about the safety of multiple courses of treatment," said George Mahaffey, president and chief executive officer of Neothetics. "We look forward to continuing our program development with future clinical trials."

More information about the Neothetics study is available by visiting www.clinicaltrials.gov .

About Neothetics, Inc.

Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The lead product candidate, LIPO-202, is for central abdominal bulging due to subcutaneous fat in non-obese subjects, an indication for which there is no FDA-approved drug. If approved, LIPO-202 may be a best-in-class non-surgical, non-ablative procedure and first-in-class injectable formulation for localized fat reduction and body contouring. For more information on Neothetics, please visit www.neothetics.com .  

Neothetics, LIPO-202, LIPO-102 and the Neothetics logo are trademarks or registered trademarks of Neothetics, Inc. Other names and brands may be claimed as the property of others.

Forward Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding Neothetics' plans to research, develop and commercialize LIPO-202 and other product candidates, as well as expected timing for reporting results from clinical trials. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon Neothetics' current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with clinical trials and obtaining regulatory approval to commercialize LIPO-202 and other product candidates, product development activities, the need to raise additional funding when needed in order to conduct our business, the degree of market acceptance of LIPO-202 by physicians, patients and others in the medical community, our reliance on third parties, including third party suppliers for manufacturing and distribution of products, regulatory developments in the United States and foreign countries, Neothetics' ability to obtain and maintain intellectual property protection for LIPO-202 and its product candidates, competition in the aesthetics industry and other market conditions. All forward-looking statements contained in this press release speak only as of the date on which they were made. Neothetics undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents the company files with the SEC available at www.sec.gov , including without limitation Neothetics' Form S-1, dated October 17, 2014, as amended.

COMPANY CONTACT: Susan A. Knudson Chief Financial Officer 858-750-1008 INVESTOR CONTACT: Fara Berkowitz, PharmD Investor Relations and Corporate Strategy MEDIA CONTACT: Rachel Hutman Canale Communications 619-849-5384

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Avenir Nears 19.99% Grid Stake After Falcon West Resource

Updated Category News Views 76

Falcon West finally put enough geological meat on the bone to make Avenir reach for its wallet. Avenir Minerals expects to buy 29,388,127 Grid Metals common shares on or about November 30, 2026, taking its non-diluted position to 19.99%. That number is not accidental. It is the usual Canadian strategic-investor ceiling before the conversation starts getting considerably...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 50

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 6

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 137

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 78

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 125

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Freedom Jet Card Launched by FlyUSA for Travelers

Updated Category News Views 311

FlyUSA Launches the Freedom Jet Card for Enhanced Travel FlyUSA is taking the world of private aviation to new heights with the introduction of its groundbreaking Freedom Jet Card. This innovative service brings a fresh approach to private flying, offering travelers the assurance of predictable pricing combined with unmatched flexibility and a wide array of aircraft...

Continue Reading
Enovix Corporation's Recent Stock Offering: A Game Changer

Updated Category News Views 104

Enovix Corporation's Public Offering Overview Enovix Corporation, a leader in high-performance battery technology, has recently announced an underwritten public offering of 10,416,667 shares of its common stock. This initiative is expected to generate gross proceeds of around $100 million, paving the way for critical advancements in their production capabilities. The...

Continue Reading
HP, First Solar, Workday Facing Headwinds as Stocks Slide

Updated Category News Views 208

Markets in Motion: A Peek at Pre-Market Action The stock market's a fickle beast, isn’t it? The Dow futures are looking moderately optimistic, gaining about 0.1% this morning. But don’t let that sunshine fool you; beneath the surface, some big names are taking hits as investors reposition themselves. HP's Disappointing Movement HP Inc. just reported its quarterly...

Continue Reading
Outset Medical Faces Class Action Amid Earnings Shortfalls

Updated Category News Views 182

Outset Medical’s Legal Challenges and Market Response Outset Medical, Inc. (NASDAQ: OM) is currently facing class action litigation, which has raised concerns among its investors. The situation arose after the company disclosed significant operational challenges and regulatory issues that have impacted its stock performance significantly. Class Action Overview Pomerantz...

Continue Reading
Schneider Electric Showcases Sustainability at Climate Week

Updated Category News Views 80

Schneider Electric's Commitment to Sustainability at Climate Week NYC Schneider Electric is making significant strides in promoting sustainability during Climate Week NYC. The company is dedicated to a thorough approach to energy transition that fosters collaboration among various sectors. This effort isn't just about encouraging eco-friendly practices; it represents a...

Continue Reading